Director

James R. Tobin

Director; Chairperson of the Board·TransMedics Group, Inc.

About

James R. Tobin has served as Chairperson of the TransMedics Board since July 2011.

He is the retired President and CEO of Boston Scientific Corporation, where he served from 1999 to 2009, was previously President and CEO of Biogen Inc. (and its President and COO from 1994 to 1997), and earlier spent 22 years with Baxter International Inc., rising from Financial Analyst to President and Chief Operating Officer.

He holds a Bachelor's Degree from Harvard College and an MBA from Harvard Business School, and served as a Lieutenant in the U.S. Navy.

Since July 2011
Age 81
Tenure 15 yrs

Also at TransMedics Group, Inc.

WM Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director EB Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee TG Thomas J. Gunderson Director; Chairperson of the Compensation Committee EJ Edwin M. Kania, Jr. Director SL Stephanie Lovell Director MR Merilee Raines Director; Chairperson of the Audit Committee

Roles

Organization Role Dates Details
TransMedics Group, Inc. Director; Chairperson of the Board July 2011–present Current role
Boston Scientific Corporation President and CEO 1999-2009 Medical device company; now retired from the role.
Biogen Inc. President and CEO; previously President and Chief Operating Officer Served as President and COO from 1994 to 1997, then President and CEO.
Baxter International Inc. Financial Analyst rising to President and Chief Operating Officer Spent 22 years with the company.

External roles

Organization Role Dates
Globus Medical Inc. Director and lead director (public company)
Lyra Therapeutics Director (public company)
Xenter, Inc. Director (private company)
Impulse Dynamics Director 2021-2023
Oxford Immunotec, Inc. Director 2014-2021

Related

Company TransMedics Group, Inc. Company hub Person Waleed H. Hassanein, M.D. Founder, President and Chief Executive Officer; Director Person Edward M. Basile Director; Chairperson of the Nominating and Corporate Governance Committee Person Thomas J. Gunderson Director; Chairperson of the Compensation Committee Person Edwin M. Kania, Jr. Director Person Stephanie Lovell Director Person Merilee Raines Director; Chairperson of the Audit Committee Person David Weill, M.D. Director Person Gerardo Hernandez Chief Financial Officer and Treasurer Person Giovanni Cecere Chief Commercial Officer Person Nicholas Corcoran Senior Vice President of Supply Chain and Operations Person Matthew Forsyth Senior Vice President, General Counsel and Corporate Secretary Person Tamer Khayal, M.D. Senior Vice President of International (former Chief Commercial Officer)
Source: TransMedics Group, Inc. proxy statement (SEC Schedule 14A)

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo